MDNA-57

N/A

Report date: 2023/02/26 21:49:45

Base Information

Drug NameMDNA-57
Drug Alias NameMDNA-57
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-4 receptor subunit alpha inhibitorsInterleukin-13 receptor subunit alpha-1 inhibitors
TargetsInterleukin-4 receptor subunit alphaInterleukin-13 receptor subunit alpha-1
Therapy Area/IndicationsSolid tumoursIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A